Details

NameSymbolSector
BAFNA PHARMACEUTICALS LIMITEDBAFNAPHPharmaceuticals
Open
169.26
High
169.26
Low
169.26
Close
169.26
Volume
1016
Exchange
nse
Time
03-Oct-2025

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Bafna Pharmaceuticals is  
Island Reversal
Estimated Stoploss of Bafna Pharmaceuticals is ₹  
176.33
Bafna Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Island Reversal
 candle pattern indicates Bafna Pharmaceuticals has chances of  
Reversalℹ
 to down trend 

Trend

Bafna Pharmaceuticals is in  
Uptrendℹ
. 
Price of Bafna Pharmaceuticals is  
Upℹ
 by  

39.45

%. 
Target
Buy @ 

84.8

Sell @ 

176.25

Current @ 

169.26

Volume

The trade volumes of Bafna Pharmaceuticals have become  
Deficientℹ
Though the volume trend for Bafna Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Bafna Pharmaceuticals is  

Down

 by  

94.85

% 

Valuation

The current market price of Bafna Pharmaceuticals is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 153cr and total assets worth ₹ 153cr, the balance sheet of Bafna Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Bafna Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Upℹ
 by  

133.33

%. 

(*Mar 2025)

50% i.e. ₹ 22cr earned in operatingℹ
47.73% i.e. ₹ 21cr spent in investingℹ
2.27% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Bafna Pharmaceuticals has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 6cr

. It is  
Downℹ
 by  

185.71

%. 

(*Mar 2024)

37.5% i.e. ₹ 9cr earned in operatingℹ
62.5% i.e. ₹ 15cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Bafna Pharmaceuticals is  

₹ 35cr

 and  

Profit

 is :  

₹ 3cr

(*Jun 2025)

Bafna Pharmaceuticals Profit is up by:  

200

% and Income is Down by:  

12.5

% 

(*Jun 2025)

The income of Bafna Pharmaceuticals is  

₹ 40cr

 and  

Profit

 is :  

₹ 1cr

(*Mar 2025)

Bafna Pharmaceuticals Profit is up by:  

100

% and Income is Up by:  

21.21

% 

(*Mar 2025)

The income of Bafna Pharmaceuticals is  

₹ 33cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Bafna Pharmaceuticals Losses increased by:  

100

% and Income is Down by:  

19.51

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.